Full Text View
Tabular View
No Study Results Posted
Related Studies
Prediction of Drug Interactions With CYP2C9 Substrates
This study has been completed.
Study NCT00226538   Information provided by Hadassah Medical Organization

First Received on September 12, 2005.   Last Updated on October 28, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy Volunteers
Interventions listed in this trial
Phenytoin
Rifampicin
Diclophenac
Fluconazole
Additional drug interventions recognized in this trial
Diclofenac
Rifampin
More general drug interventions related to this trial
14-alpha Demethylase Inhibitors
Analgesics
Analgesics, Non-Narcotic
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antibiotics, Antitubercular
Anticonvulsants
Antifungal Agents
Antirheumatic Agents
Antitubercular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Leprostatic Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Hadassah Medical Organization


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services